Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexette Foam in Plaque Psoriasis
NCT02368210Phase 3Completed
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Halobetasol propionate 0.05% lotion in plaque psoriasis. Started Jan 2015; status: completed.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02368210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368210.